ArticleFrontiers in neurology
Predictive value of NLR combined with CAR in patients with cerebral hemorrhage undergoing maintenance hemodialysis.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the predictive value of the neutrophil-to-lymphocyte ratio (NLR), the C-reactive protein-to-albumin ratio (CAR), and their combined use for intracerebral hemorrhage (ICH) in patients undergoing maintenance hemodialysis (MHD), and to assess whether the combined indicator offers incremental discriminative ability beyond either marker alone. Methods: A total of 335 patients with end-stage renal disease receiving MHD at our hospital between January 2021 and December 2025 were retrospectively enrolled. Based on the occurrence of ICH, patients were divided into an ICH group ( Results: NLR and CAR levels were significantly higher in the ICH group than in the non-ICH group ( Conclusion: NLR and CAR are independent risk markers for ICH in MHD patients, and their combination significantly improves predictive accuracy. This simple, cost-effective inflammation-nutrition composite indicator may serve as a practical tool for the early identification of dialysis patients at high risk of ICH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.